The award will be presented June 5 at the Inaugural Session of the society's 40th Annual Meeting at the Ernest N. Morial Convention Center in New Orleans.
The ASCO Special Recognition Award winner is chosen by a selection committee, chaired this year by Immediate Past President Paul A. Bunn, Jr., M.D., who is a professor and director of the University of Colorado Cancer Center in Denver, and also a long-time member of the AACR.
In choosing Foti for the honor, the committee cited, "her instrumental role in the development of the AACR/ ASCO Joint Workshop, 'Methods in Clinical Cancer Research,' which has served as the prototype for subsequent workshops designed to introduce beginning oncologists in Europe and Australia to the essentials of effective clinical trials design." They noted also Foti's efforts "to provide vital links between translational scientists and clinicians," and her fostering of "important connections between these two research groups."
"I am deeply honored to receive this award, which is all the more meaningful coming from ASCO," Foti said. "ASCO is one of our most valued and long-term collaborators in strengthening cancer education and communication. Our close relationship has become increasingly important in this modern era of translational cancer research and synergistic targeted therapies," she added.
A native of Philadelphia, Foti has dedicated virtually her entire professional career to the AACR, first as an editorial assistant for the associatio
'"/>
Contact: Elizabeth Tait
tait@aacr.org
215-440-9300
American Association for Cancer Research
3-Jun-2004